115 related articles for article (PubMed ID: 2187071)
1. The effect of zidovudine on platelet count in HIV-infected individuals.
Montaner JS; Le T; Fanning M; Gelmon K; Tsoukas C; Falutz J; O'Shaughnessy M; Wainberg MA; Ruedy J
J Acquir Immune Defic Syndr (1988); 1990; 3(6):565-70. PubMed ID: 2187071
[TBL] [Abstract][Full Text] [Related]
2. Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial.
Gelmon K; Montaner JS; Fanning M; Smith JR; Falutz J; Tsoukas C; Gill J; Wells G; O'Shaughnessy M; Wainberg M
AIDS; 1989 Sep; 3(9):555-61. PubMed ID: 2528969
[TBL] [Abstract][Full Text] [Related]
3. HIV-seropositive thrombocytopenia: the action of zidovudine.
Boyar A; Beall G
AIDS; 1991 Nov; 5(11):1351-6. PubMed ID: 1768384
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial.
Marroni M; Gresele P; Landonio G; Lazzarin A; Coen M; Vezza R; Sinnone MS; Boschetti E; Nosari AM; Stagni G; Nenci GG; Pauluzzi S
Ann Intern Med; 1994 Sep; 121(6):423-9. PubMed ID: 8053616
[TBL] [Abstract][Full Text] [Related]
5. Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.
Peña JM; Arnalich F; Barbado FJ; Dominguez A; Mostaza J; Valencia ME; Vazquez JJ
Acta Haematol; 1990; 83(2):86-8. PubMed ID: 2106201
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.
Ballem PJ; Belzberg A; Devine DV; Lyster D; Spruston B; Chambers H; Doubroff P; Mikulash K
N Engl J Med; 1992 Dec; 327(25):1779-84. PubMed ID: 1435932
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.
Landonio G; Cinque P; Nosari A; Gafa S; Rizzo F; Coen M; Tirelli U; Caggese L; di Luzio Paparatti U; Lazzarin A
AIDS; 1993 Feb; 7(2):209-12. PubMed ID: 8466682
[TBL] [Abstract][Full Text] [Related]
8. The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV.
Rarick MU; Espina B; Montgomery T; Easley A; Allen J; Levine AM
AIDS; 1991 Nov; 5(11):1357-61. PubMed ID: 1768385
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication.
Cinque P; Landonio G; Lazzarin A; Nosari AM; Ruggieri A; Coen M; Meraviglia P; Gringeri A; Gallo L; Quirino T
Eur J Haematol; 1993 Jan; 50(1):17-21. PubMed ID: 8094675
[TBL] [Abstract][Full Text] [Related]
10. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection.
Oksenhendler E; Bierling P; Ferchal F; Clauvel JP; Seligmann M
Ann Intern Med; 1989 Mar; 110(5):365-8. PubMed ID: 2916807
[TBL] [Abstract][Full Text] [Related]
11. Zidovudine and lamivudine: results of phase III studies.
Staszewski S
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
[TBL] [Abstract][Full Text] [Related]
12. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Staszewski S; Loveday C; Picazo JJ; Dellarnonica P; Skinhøj P; Johnson MA; Danner SA; Harrigan PR; Hill AM; Verity L; McDade H
JAMA; 1996 Jul; 276(2):111-7. PubMed ID: 8656502
[TBL] [Abstract][Full Text] [Related]
14. Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Demeter LM; Hughes MD; Coombs RW; Jackson JB; Grimes JM; Bosch RJ; Fiscus SA; Spector SA; Squires KE; Fischl MA; Hammer SM
Ann Intern Med; 2001 Dec; 135(11):954-64. PubMed ID: 11730396
[TBL] [Abstract][Full Text] [Related]
15. Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine).
Gottlieb MS; Wolfe PR; Chafey S
AIDS Res Hum Retroviruses; 1987; 3(2):109-14. PubMed ID: 3113461
[TBL] [Abstract][Full Text] [Related]
16. Treatment of human immunodeficiency virus-related thrombocytopenia with zidovudine.
Pottage JC; Benson CA; Spear JB; Landay AL; Kessler HA
JAMA; 1988 Nov; 260(20):3045-8. PubMed ID: 2972851
[TBL] [Abstract][Full Text] [Related]
17. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
Staszewski S; Keiser P; Montaner J; Raffi F; Gathe J; Brotas V; Hicks C; Hammer SM; Cooper D; Johnson M; Tortell S; Cutrell A; Thorborn D; Isaacs R; Hetherington S; Steel H; Spreen W;
JAMA; 2001 Mar; 285(9):1155-63. PubMed ID: 11231744
[TBL] [Abstract][Full Text] [Related]
18. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).
Ann Intern Med; 1988 Nov; 109(9):718-21. PubMed ID: 3190058
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group.
Katlama C; Ingrand D; Loveday C; Clumeck N; Mallolas J; Staszewski S; Johnson M; Hill AM; Pearce G; McDade H
JAMA; 1996 Jul; 276(2):118-25. PubMed ID: 8656503
[TBL] [Abstract][Full Text] [Related]
20. Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017).
Mulder JW; Cooper DA; Mathiesen L; Sandström E; Clumeck N; Gatell JM; French M; Donovan B; Gray F; Yeo JM
AIDS; 1994 Mar; 8(3):313-21. PubMed ID: 7913326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
